secwatch.observer — SEC 8-K summary
======================================

Issuer:     AIM ImmunoTech Inc. (AIM)
CIK:        0000946644
Form:       8-K
Filed at:   2022-11-09T23:59:59+00:00
Accession:  0001493152-22-031043
Event type: other
Sentiment:  negative
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

AIM ImmunoTech say-on-pay fails at 2022 annual meeting; directors elected
-------------------------------------------------------------------------

- Directors elected: Thomas K. Equels (7.65M for, 4.71M withheld), William M. Mitchell (4.33M for, 8.03M withheld), Stewart L. Appelrouth (4.32M for, 8.04M withheld).
- Ratification of BDO USA as auditor passed: 19.95M for, 1.88M against, 0.37M abstain.
- Non-binding advisory vote on executive compensation failed: 2.04M for, 10.21M against, 0.11M abstain, with 9.83M broker non-votes.
- Approximately 48.05M shares eligible to vote; quorum of 40% met.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/946644/000149315222031043/0001493152-22-031043-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/946644/000149315222031043/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-22-031043

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer